Related Experiment Video

Updated: Feb 16, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

5.4K

MEDICAL MANAGEMENT OF DILATED CARDIOMYOPATHY IN LIVINGSTONE FRUIT BATS ( PTEROPUS LIVINGSTONII)

Rowena Killick, Alberto Rodriguez Barbon, Michelle Barrows

    Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians
    |January 4, 2018
    PubMed

    Insights

    Treatment for dilated cardiomyopathy in Livingstone fruit bats (Pteropus livingstonii) involved diuretics, angiotensin-converting enzyme inhibitors (ACEI), and pimobendan. This review details drug dosages for managing heart failure in these bats.

    Area of Science:

    • Veterinary Cardiology
    • Zoological Medicine
    • Conservation Medicine

    Background:

    • Dilated cardiomyopathy (DCM) is a serious cardiac condition affecting captive Livingstone fruit bats (Pteropus livingstonii).
    • Effective medical management strategies for DCM in this specific Pteropus species are crucial for improving outcomes.

    Purpose of the Study:

    • To document and review the pharmacological treatments used for diagnosed cases of dilated cardiomyopathy in captive Livingstone fruit bats.
    • To provide a reference for veterinarians managing heart failure in Pteropus species, particularly P. livingstonii.

    Main Methods:

    • Retrospective review of eleven cases of diagnosed and treated dilated cardiomyopathy in captive Livingstone fruit bats over seven years.
    • Analysis of drug classes (diuretics, ACE inhibitors, pimobendan) and specific dosages administered.

    Main Results:

    • Eleven cases of dilated cardiomyopathy were identified and treated.
    • Most bats received a combination of a diuretic (furosemide and/or spironolactone) and an angiotensin-converting enzyme inhibitor (ACEI) or pimobendan.
    • One bat, diagnosed pre-clinically, is currently treated with pimobendan alone.

    Conclusions:

    • Diuretics, ACE inhibitors (imidapril), and pimobendan are key therapeutic agents for managing dilated cardiomyopathy in Livingstone fruit bats.
    • Specific dosage ranges for furosemide, spironolactone, imidapril, and pimobendan are provided for clinical application.
    • This review offers valuable data for veterinary professionals treating heart failure in Pteropus species.

    Keywords:
    CardiomyopathyPteropus livingstoniifurosemideimidaprilpimobendanspironolactone

    More Related Videos

    Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan07:55

    Standard Operating Procedure for Lyssavirus Surveillance of the Bat Population in Taiwan

    Published on: August 27, 2019

    8.0K
    Author Spotlight: Sieving Fruit Pulp to Detect Immature Tephritid Fruit Flies in the Field04:21

    Author Spotlight: Sieving Fruit Pulp to Detect Immature Tephritid Fruit Flies in the Field

    Published on: July 28, 2023

    2.6K

    Related Concept Videos

    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    591
    Cardiomyopathy VI: Nursing Management01:29

    Cardiomyopathy VI: Nursing Management

    Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
    372
    Endocarditis III: Medical Management01:18

    Endocarditis III: Medical Management

    Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
    269
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
    225
    Pericarditis III: Medical Management01:17

    Pericarditis III: Medical Management

    The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
    377
    Heart Failure V: Medical Management01:30

    Heart Failure V: Medical Management

    Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
    369